Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

Mindstrong Health and Takeda Partner to Explore Development of Digital Biomarkers for Mental Health Conditions


PALO ALTO, Calif., Feb. 27, 2018 /PRNewswire/ -- Mindstrong Health, a startup transforming the diagnosis and treatment of neuropsychiatric disorders, has entered into a partnership with Takeda Pharmaceutical Company Limited (TSE: 4502) to explore the development of digital biomarkers for selected mental health conditions, in particular schizophrenia and treatment-resistant depression.

Mindstrong Health

"Takeda shares our goal of using innovative technology to gain insights that will improve outcomes for people living with mental health conditions," said Dr. Paul Dagum, Founder and CEO of Mindstrong Health. "We are pleased to partner with them to implement digital technology in the clinical development of novel assets and, hopefully, allow for faster delivery of meaningful therapies to patients."

Mindstrong Health has developed digital biomarkers that continuously measure brain function from passively collected smartphone data. Takeda's technology, combined with the powerful Mindstrong Health platform will potentially enable the application of digital biomarkers to stratify mental health conditions and predict remission with novel therapeutic interventions.

"Mental health disorders are complex, multifaceted conditions, and drug development in this area of unmet need is slow to progress," said Emiliangelo Ratti, Head, Neuroscience Therapeutic Area Unit at Takeda. "This partnership with Mindstrong Health exemplifies Takeda's motivation to engage in digital technologies to improve the clinical assessment of patients with mental health conditions who lack adequate treatment options."

About Mindstrong Health
Mindstrong Health is redefining the management and treatment of neuropsychiatric and neurodegenerative disorders with technology to measure brain function continuously from human-computer interactions on ubiquitous mobile devices. The company is based in Palo Alto, California and is backed by Foresite Capital, ARCH Venture Partners, Optum Ventures, Berggruen Holdings and One Mind Brain Health Impact Fund.  To learn more about Mindstrong Health, visit www.mindstronghealth.com

Media Contacts:

For Mindstrong:
Paul Dagum, CEO
[email protected] 
+1-415-378-5456

 

SOURCE Mindstrong Health


These press releases may also interest you

at 09:20
Greenlight®, the award-winning money and safety app for families, today announced the launch of industry-first driving safety tools designed for families to help teens become more confident drivers. Driving scores, reports, and real-time alerts are...

at 09:20
Innventure LLC ("Innventure" or "the Company"), an enterprise growth engine, today announced that Accelsius Inc. ("Accelsius"), the thermal management technology company Innventure launched in 2022, unveiled its two-phase, direct-to-chip liquid...

at 09:20
Bio-Rad Laboratories, Inc. , a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2024 on Tuesday, May 7, 2024, following the close of the market. Management will...

at 09:20
AffiniPay, the leader in online payments and software solutions for professionals, has announced the launch of its expansion into Puerto Rico for LawPay and CPACharge. With a strong presence established in the United States and Canada serving over...

at 09:20
Cart.com, a leading provider of unified commerce and logistics solutions that enable merchants to sell and fulfill wherever their customers are, today announced the company will work with Walmart Marketplace's team to simplify onboarding and develop...

at 09:18
The Stage Front Stadium in Barcelona underwent a revolutionary transformation thanks to the collaboration between RCD Espanyol, the investment group Publimaes, and LED DREAM Group. The installation of an impressive LED screen of nearly 200 square...



News published on and distributed by: